Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Other Working Capital Changes (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Other Working Capital Changes data on record, last reported at $5.2 million in Q4 2021.

  • For Q4 2021, Other Working Capital Changes rose 970.0% year-over-year to $5.2 million; the TTM value through Dec 2021 reached $3.7 million, up 551.76%, while the annual FY2025 figure was -$1.6 million, 12.63% down from the prior year.
  • Other Working Capital Changes reached $5.2 million in Q4 2021 per COGT's latest filing, up from -$2.0 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $5.2 million in Q4 2021 and bottomed at -$3.7 million in Q3 2019.
  • Average Other Working Capital Changes over 4 years is $197500.0, with a median of $129500.0 recorded in 2018.
  • Peak YoY movement for Other Working Capital Changes: skyrocketed 1621.13% in 2019, then tumbled 2376.47% in 2020.
  • A 4-year view of Other Working Capital Changes shows it stood at -$213000.0 in 2018, then surged by 1621.13% to $3.2 million in 2019, then plummeted by 84.88% to $490000.0 in 2020, then surged by 970.0% to $5.2 million in 2021.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $5.2 million in Q4 2021, -$2.0 million in Q3 2021, and $1.9 million in Q2 2021.